Previous close | 1,522.00 |
Open | 1,531.00 |
Bid | 1,514.00 x 0 |
Ask | 1,515.50 x 0 |
Day's range | 1,513.00 - 1,542.50 |
52-week range | 790.00 - 1,636.00 |
Volume | 75,352 |
Avg. volume | 747,745 |
Market cap | 6.001B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 22.80 |
EPS (TTM) | 66.40 |
Earnings date | 26 Mar 2021 |
Forward dividend & yield | 0.35 (2.35%) |
Ex-dividend date | 22 Oct 2020 |
1y target est | 1,664.33 |
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has been awarded a contract to deliver 26 X-ray inspection systems for the Phoenix Suns Arena. The inspection systems will be used to screen deliveries as well as personal belongings of all those entering the arena.
Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
Smiths Detection, a global leader in threat detection and security screening technologies, was granted an AOAC INTERNATIONAL Performance Test MethodSM (PTM) program certification number 122005 for its Listeria CANARY® assay. The assay, used in the company’s Zephyr pathogen identifier, gives food and beverage companies a new, rapid solution to screen and protect against dangerous pathogens that are a common contaminate of concern in food-processing environments.